Orient Pharma Co., Ltd. (TPEX:4166)

Orient Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,171	8,029	4,461	3,908	3,497	2,721
Market Cap Growth	63.72%	80.00%	14.13%	11.77%	28.52%	20.11%
Enterprise Value	7,485	8,510	5,080	4,148	3,763	3,110
Last Close Price	32.15	36.00	20.00	20.90	18.70	14.55
PE Ratio	59.79	74.78	200.14	-	-	-
PS Ratio	5.67	6.57	5.01	7.64	7.55	6.60
PB Ratio	3.90	4.49	2.67	3.59	3.13	2.24
P/TBV Ratio	5.19	6.10	3.92	3.63	3.17	2.28
P/FCF Ratio	25.30	47.32	-	-	-	-
P/OCF Ratio	23.18	40.76	-	343.32	-	-
EV/Sales Ratio	5.92	6.96	5.71	8.10	8.12	7.55
EV/EBITDA Ratio	24.50	31.21	36.55	333.67	-	-
EV/EBIT Ratio	43.61	53.89	208.88	-	-	-
EV/FCF Ratio	26.41	50.16	-	-	-	-
Debt / Equity Ratio	0.29	0.31	0.43	0.47	0.37	0.27
Debt / EBITDA Ratio	1.72	1.87	4.52	20.74	-	-
Debt / FCF Ratio	1.85	3.22	-	-	-	-
Asset Turnover	-	0.48	0.40	0.28	0.26	0.25
Inventory Turnover	-	2.23	1.97	2.03	2.17	2.67
Quick Ratio	0.97	0.82	0.53	0.51	0.55	1.08
Current Ratio	1.69	1.50	1.11	1.21	1.05	1.73
Return on Equity (ROE)	6.83%	6.21%	1.62%	-2.61%	-8.80%	-15.56%
Return on Assets (ROA)	-	3.88%	0.69%	-1.44%	-4.76%	-6.30%
Return on Capital (ROIC)	4.52%	4.18%	0.76%	-1.67%	-5.43%	-7.20%
Return on Capital Employed (ROCE)	8.30%	7.80%	1.20%	-	-	-
Earnings Yield	1.67%	1.34%	0.50%	-0.74%	-2.94%	-6.30%
FCF Yield	3.95%	2.11%	-3.52%	-0.43%	-3.43%	-8.17%
Buyback Yield / Dilution	-	-	-19.27%	0.00%	-10.40%	-8.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.